Social Icons

Friday 29 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

Idea Cellular slumps post Q4FY16 earnings

Nifty Futures Tips
Shriram Trans Q4: Net Profit at Rs144 Cr
Shriram Trans Q4: Net Profit at Rs144 Cr: Shriram Tran 927.75 -3.79% NII at Rs1,475 Cr
Total Income at Rs2918 Cr Vs Rs2312.33 Cr (YoY)
FY16 net profit at Rs1178.20 Cr vs Rs1237.81 Cr (YoY)
FY16 total income at Rs10245.26 Cr vs Rs8644.73 Cr (YoY)

ICICI Bank Q4FY16 results: Asset quality deteriorates
ICICI bank has reported deteriorated asset quality for Q4FY16 as G NPA rose by 110 BPS to 5.82% QoQ as accounts worth around Rs7000 crore slipped into NPA, however RBI’s AQR has been completely taken into account.
The Bank reported a modest 6.4% growth in Net interest income while the non interest income was up by 46.1% YoY. Provisions rose sharply by 147.4% YoY owing to Rs3600 crore additional contingent provisioning done during the quarter.

Profit during the quarter came in at Rs702 crore (down 76% YoY) owing to higher provisioning. We currently have a hold rating on the stock and would come out with detailed note post management interaction.

Lupin surges on re-introducing Methergine Oral Tablets
Lupin rose over 2%, touching to Rs1617.65, after the company announced that its US subsidiary has re-introduced Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage.

Lupin and its US subsidiary, Lupin Pharmaceuticals, Inc. have announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg in the US for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only FDA-approved oral uterotonic and is a preferred oral agent in the management of PPH, according to guidelines issued by the American Congress of Obstetricians and Gynecologists (ACOG).

Idea Cellular slumps post Q4FY16 earnings
Shares of Idea Cellular slumped 6% to Rs119.35 on NSE post Q4FY16 earnings which beat estimates but share price fell as volume growth remained soft.

Idea cellular posted strong operational performance, its operating profit grew by 15.6% on a sequential basis, backed by pricing growth in voice (+4.7% qoq) as well as data(+2.7% qoq) segment, but the growth volume growth tapered for both the segments at 1.2% and 1.5% qoq).Higher depreciation & interest cost resulted in 24.7% qoq decline in net earnings.

Ajanta Pharma Q4 consolidated net profit up 43% (YoY)
Ajanta Pharma has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone (YoY)
For the Quarter ended March 31, 2016
The Company has posted a net profit of Rs135.71 crore Vs Rs84.31 crore.
Total Income increased to Rs443.26 crore Vs Rs371.68 crore.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Thursday 28 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

TOP CORPORATE NEWS- 28 Apr 2016

Nifty Future Tips

Dabur India Q4 consolidated net profit up 17% (YoY)
Dabur India has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs289.03 crore Vs Rs212.94 crore.
Total Income increased to Rs1566.89 crore Vs Rs1429.21 crore.

DLF launches Mall of India at investment of Rs1700 croresa
DLF launches Mall of India (2 million sq ft built at an investment of Rs1700 crore) – Positive for DLF
As per media reports, DLF officially launched Mall of India in Noida. The mall built at an investment of Rs1700 crore is spread across 2 million square feet.
As much as 95% of the space in the mall has been leased out with as many as 14 anchor partners.

ACC Q1 consolidated net profit down 4% (YoY)
ACC Ltd has announced the following results for the quarter ended March 31, 2016
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs232.19 crore Vs Rs240.55 crore.
Total Income has decreased to Rs3039.52 crore Vs Rs3139.22 crore.

Ceat Q4 consolidated net profit up 11% (YoY)
Ceat has announced the following Q4 & FY16 audited results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016 (YoY)
The Company has posted a net profit of Rs102.23 crore Vs Rs89.44 crore.
Total Income decreased to Rs1397.55 crore Vs Rs1431.77 crore.

Aurobindo gets tentative nod from USFDA for Tadalafil
Aurobindo gets tentative nod from USFDA to manufacture and market Tadalafil, used in treating erectile dysfunction and for treatment of pulmonary hypertension – Positive for Aurobindo.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Wednesday 27 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

TOP CORPORATE NEWS- 27 Apr 2016

Nifty Futures Tips
Alembic Pharma Q4: Cons Net Profit +29.6% at Rs91.2 Cr
Alembic Pharma Q4: Cons Net Profit +29.6% At Rs.91.2 Cr Vs Rs.70.3 Cr (YoY)
Cons Total Income +24.6% At Rs.626.6 Cr Vs Rs.503 Cr (YoY)
Cons EBITDA At Rs.143.3 Cr Vs Rs.98 Cr (YoY)
Cons EBITDA +46.3% At Rs.143.3 Cr Vs Rs.98 Cr (YoY)
India Generic Biz Revenue -46% At 17.4 Cr Vs Rs.32.1 Cr (YoY)
India Branded Biz Revenue +12% At 259.6 Cr Vs Rs.232.1 Cr (YoY)
Intl Biz Revenue +20% At 190.2 Cr Vs Rs.158.3 Cr (YoY)


Axis Bank drops post Q4FY16 results

Shares of Axis Bank dropped 3.4% to Rs464 on NSE post Q4FY16 result update where business growth remained healthy; Asset quality stable; PT revised to Rs590.


NII up 19.8%; Margins expand: Axis bank reported a strong 19.8% growth in Net interest for Q4FY16 owing to 20.5% jump in the advances and expansion in Net Interest Margins (up 16 BPS Yo and 18 BPS QoQ). Non-interest income growth was flat as treasury profit declined by 65.4% YoY, however retail fee income showed a growth of 15.1% YoY. Provisions for Q4FY16 surged by 64.6% YoY owing to Rs300 crore contingent provisions made during the quarter.



Yes Bank reports robust operating performance; Asset quality deteriorates

Yes Bank has announced the following audited Q4 & FY16 results for the quarter & year ended March 31, 2016:


Standalone

The Bank has posted a net profit of Rs702.11 crore Vs Rs550.99 crore (YoY).
Total Income increased to Rs4331.11 crore Vs Rs3678.83 crore (YoY).


M&M launches bigger variant of Bolero pick-up truck

M&M launches bigger variant of the Bolero pick-up truck; to further consolidate leadership in pick up category,M&M launched the new “Big Bolero” pick-up truck in two variants on with 1,250 Kg payload and the other with 1,500 Kg payload.


The pick-up is powered by the proven MDI Turbo charged engine. The vehicle is priced at Rs6.15 lakh (BS3 ex showroom Pune) and Rs6.3 lakh (BS4 ex-showroom Pune).



Aurobindo Pharma receives USFDA approval for Oxymorphone Tablets

Aurobindo Pharma receives USFDA Approval for Oxymorphone Hydrochloride Tablets – Positive for Aurobindo.


Aurobindo gets final approval from USFDA to manufacture and market Oxymorphone Hydrochloride Tablets, used to help relieve moderate to severe acute pain where the use of an opioid is appropriate.



The approved product has an estimated market size of US$ 55.5 million for the twelve months ending February 2016 according to IMS.


Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Tuesday 26 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

TOP CORPORATE NEWS- 26 Apr 2016

Nifty Futures Tips

Maruti Suzuki Q4 net profit down 12% to Rs1134 cr (YoY)
Maruti Suzuki India has announced the following Q4 & FY16 results for the quarter & year ended March 31, 2016:

Standalone
For the Quarter ended March 31, 2016 (Unaudited)
Net Profit falls by 11.72% to Rs1133.60 crore Vs Rs1284.20 crore (YoY).
Total Income increased by 10.62% to Rs15426.90 crore Vs Rs13944.70 crore (YoY).

M&M launches Scorpio Adventure at Rs13.07 lakh
M&M has launched the Scorpio Adventure Limited Edition utility vehicle at a price of Rs13.07 lakh (Ex-showroom pre-Octroi, Navi Mumbai) and is based on the top-of-the-line S10 variant of the existing Scorpio.

While the vehicle's interior remains unchanged, it looks slightly different from outside with Mist Silver and White dual-tone with adventure-themed decals, gun metal-finished alloy wheels and red brake callipers.

BPCL receives green nod for Rs694 crore project
BPCL has received green nod for its Rs694 crore project of developing LPG 1 mmpta import terminal as well as storage, bottling and bulk distribution facilities at Haldia Dock Complex in West Bengal.

Sun Pharma, Govt in PPP for malaria eradication
Sun Pharmaceuticals has entered into a public private partnership (PPP) with the Union and Madhya Pradesh governments for a campaign to ensure a malaria-free India.

In this partnership, the three stakeholders will establish a phased malaria eradication project for most endemic districts of Madhya Pradesh.

Moreover, the company and the Indian Council of Medical Research (ICMR) may enter a joint drug development programme to manufacture new patented drugs.

Hindalco up after Aditya to accept improved Metals X bid
Hindalco Industries has announced that it has communicated to Aditya Birla Minerals ( ABML) its intention to accept the improved offer by Metal X to acquire shares of ABML subject to receiving the approval of the Reserve Bank of India ( RBI) and no bona fide superior proposal being announced by a third party within 5 business days of Metals X announcing its intention to make the offer.

Metal X, a listed company in Australia has made an announcement regarding its intention to improve its ongoing takeover offer for acquiring shares of ABML under the relevant laws of Australia. ABML is a subsidiary of Hindalco Industries and listed on Australian Stock Exchange.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900


Friday 22 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

Maruti Suzuki’s Baleno receives 3-star rating in NCAP test

Nifty Futures Tips
Aurobindo Pharma gets USFDA nod for gNexium
Aurobindo gets approval from the USFDA to manufacture and market gNexium, used to treat gastric ulcers. The launch of the product will be based on settlement terms/litigation outcome with Astrazeneca.This is the 70th ANDA (including 15 tentative approvals) to be approved from Unit 7 formulation facility.


HDFC Bank Q4 profit in line with estimates

HDFC Bank has announced the following audited results for the quarter & year ended March 31, 2016:

Standalone
For the Quarter ended March 31, 2016
Net Profit rose by 20.21% to Rs3374.22 crore Vs Rs2806.91 crore (YoY).
Total Income increased by 21.14% to Rs18862.61 crore Vs Rs15570.13 crore (YoY).

Dewan Housing rises on talks to buy Andromeda
Shares of Dewan Housing rose 2% to Rs208 on NSE in an otherwise weak market on reports that the company is in talks to buy Andromeda for up to Rs250 crore – Positive as enhanced distribution network would support loan growth.Dewan Housing Finance Ltd is in talks to acquire Andromeda Sales and Distribution Pvt. Ltd, one of the largest distributors of loans, mortgage, financing and financial instruments in India.


Maruti Suzuki’s Baleno receives 3-star rating in NCAP test

Leading Auto giant, Maruti Suzuki’s premium hatchback Baleno has received a 3-star rating out of 5-star in a crash test with standard equipment by automobile safety agency Euro NCAP (New Car Assessment Programme).The Japanese-Indian auto-maker’s global model Baleno is manufactured only in India. The model received a four star rating in Safety pack.

Emami's FY16 results on May 05, 2016
Emami Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 05, 2016, inter alia, to consider Audited Annual Accounts of the Company for the Financial Year ended March 31, 2016 and to consider, if thought fit, to recommend the Dividend for the Financial Year 2015-16.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Thursday 21 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

TOP CORPORATE NEWS- 21 Apr 2016

Nifty Future Tips
IndusInd Bank Q4: Net Profit at Rs620 Cr Vs Rs495.3 Cr (YoY)

IndusInd Bank Q4: Net Profit at Rs620 Cr Vs Rs495.3 Cr (YoY)
Gross NPA At 0.87% Vs 0.82% (QoQ)
Net NPA At 0.36% Vs 0.33% (QoQ)
Gross NPA at Rs.776.8 Cr Vs Rs.681.1 Cr (QoQ)
Net NPA at Rs.321.7 Cr Vs Rs.273.3 Cr (QoQ)
Provisions at Rs.213.6 Cr Vs Rs.177 Cr (QoQ)
NII at Rs.1, 268.2 Cr Vs Rs.925.1 Cr (YoY)

Glenmark Pharma gets 483 form for Pithampur plant
Glenmark Pharma gets 483 form from USFDA for Pithampur plant.
Although the news is sentimentally negative for the company, according to the management clarification, Zetia (one of the key launch) has been filed from three facilities, hence it’s a breather for the stock.

Cyient Q4 consolidated net profit at Rs66 cr (YoY)
Cyient has announced the following audited results for the quarter & year ended March 31, 2016:
Standalone

For the Quarter ended March 31, 2016
The Company has posted a net profit of Rs24.92 crore Vs Rs72.48 crore (YoY).
Total Income has decreased to Rs302.86 crore Vs Rs352.22 crore (YoY).

Alembic Pharma spurts on JV with Orbicular Pharma
Shares of Alembic Pharmaceuticals Ltd (APL) spurted 7.53% to Rs615 on NSE after the company today said that it has entered into a joint venture with Orbicular Pharmaceutical Technologies and Dr M S Mohan to develop, manufacture and commercialise dermatology products for global markets.

APL and Orbicular will own 60 percent and 40 percent of the equity capital of Aleor when the transaction is completed. Total Income has increased to Rs203.15 crore Vs Rs183.77 crore (YoY).
RIL to expand its GenNext Venture, collaborates with Invest Ottawa.

The Indian conglomerate, Reliance Industries Ltd (RIL) has announced to partner with Invest Ottawa, an economic development agency for the city of Ottawa. The partnership will help Reliance Industries GenNext Ventures and the Canadian startups to grow parallel exploiting markets for the best.

The two-year MOU was signed in Mumbai in the presence of eminent members of both sides. VP Rajan Luthra represented Reliance Industries where as Invest Ottawa was represented by its CEO, Bruce Lazenby. The meet also saw the presence of the Mayor of the City of Ottawa Jim Watson and Canadian Consul General in Mumbai Jordan Reeves.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Wednesday 20 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

TCS drops as Q4FY2016 margins miss the mark

Nifty Futures Tips
TCS drops as Q4FY2016 margins miss the mark
Shares of TCS dropped to Rs 2450 on NSE post Q4FY2016 results despite inline revenue performance as margins miss the mark.

Inline revenues, margins missed the mark: after six back to back quarter of revenues miss, TCS has delivered a inline revenues performance with 2.1% qoq growth on CC basis (1.5% on reported basis), volume growth was decent at 3.2%, while realization was down by 1.1% qoq.

Dr Reddys launches ZEMBRACE SymTouch
Dr Reddys Laboratories launches ZEMBRACE SymTouch ( sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine in the US – Positive for Dr Reddy.

CRISIL Q1 consolidated net profit up 40% (YoY)
CRISIL has announced the following Q1 results for the quarter ended March 31, 2016
Unaudited Standalone results for the Quarter ended March 31, 2016:
The Company has posted a net profit of Rs65.64 crore Vs Rs45.61 crore (YoY).
Total Income has increased to Rs267.23 crore Vs Rs227.30 crore (YoY).

TV18 Broadcast Q4 consolidated net profit down 14% (YoY)
TV18 Broadcast has announced the following Q4 results for the quarter & year ended March 31, 2016:
Standalone.For the Quarter ended March 31, 2016 (Unaudited)

The Company has posted a net profit of Rs58.67 crore Vs Rs60.90 crore (YoY).Total Income has increased to Rs203.15 crore Vs Rs183.77 crore (YoY).

HDFC rises after board approves stake sale
Housing Development Finance Corporation (HDFC) surged nearly 3%, touching to Rs1158.5, after the company announced that it has in-principle agreed to sell up to 10% of its stake in insurance arm HDFC Standard Life through offer for sale.

The board of directors of HDFC Standard Life Insurance Company Ltd (HDFC Life), a material non listed subsidiary of the Corporation, at its meeting held on April 18, 2016, approved taking steps to initiate the process for an initial public offer (IPO) by way of offer for sale by the Corporation, up to 10% of the paid-up and issued equity share capital of HDFC Life.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900

Monday 18 April 2016

expr:content='data:blog.blogId' itemprop='blogId'/>

Adani gains on authorisation for $21.7 billion coal project

Nifty Futures Tips
LIC Housing Q4 net profit up 18% (YoY)
LIC Housing Finance Ltd has announced the following results for the quarter & year ended March 31, 2016:

Standalone:For the Quarter ended March 31, 2016 (Audited)
Net Profit surged by 18.46% to Rs448.02 crore Vs Rs378.18 crore (YoY).Total Income increased by 14.44% to Rs3273.94 crore Vs Rs2860.59 crore (YoY).

Alkem Labs slumps facing trial by German regulator
Shares of Alkem Labs dropped 5% to Rs1276 on NSE in an otherwise positive market as the company has been accused of fudging trial data by German regulator.

Alkem Laboratories has been accused by Germany`s health regulator of fudging data on clinical trials of an antibiotic and brain disorder drug, becoming the third Indian firm to be scrutinised since 2014 for suspected manipulation of trial data.

Reliance Industries plans to shut down unit of SEZ Refinery
Reliance Industries is planning to shut down one crude distillation unit of SEZ Refinery for routine Maintenance & Inspection activities from May 01, 2016, for about 3 weeks.

Adani gains on authorisation for $21.7 billion coal project
Adani Enterprises has got authorization by traditional land owners for its 21.7 billion dollar coal mine project in Australia.
The stock opened at Rs81.25 marking days low at Rs81.20 with an intraday high of Rs83.80 and is currently trading at Rs82.70 up by 2.54% on NSE so far.

Aditya Birla subsidiary to sell 15% stake in company
Media flash- Aditya Birla’s subsidiary My universe is looking to sell 15% stake in the company for $100 million, leading to a consideration of $670 million.This is sentimentally positive for the Company.

Our Some Best Services Read it Here…
 CapitalStars Financial Research Financial Advisory Services 

www.capitalstars.com | T:+91-731-6790000,6669900
 

Do U Want !!!!

Our Special Services

sensex-nifty-charts

 
Blogger Templates